We are monitoring the impact of COVID-19 on Europe Chlamydia Infection Diagnostics And Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4961
Share on
Share on

Europe Chlamydia Infection Diagnostics and Therapeutics Market Research Report – Segmented By Product Type, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4961
Pages: 145

The size of the Europe Chlamydia Infection Diagnostics and Therapeutics market was around USD 0.56 billion in 2020. It is expected to grow at a CAGR of 5.9% to reach USD 0.75 billion by 2025. It captures 25% of the global market.

Chlamydia is a sexually transmitted disease. The symptoms do not occur early on. It is usually prevalent in areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade.

Increasing number of cases of these diseases better and complete reporting in emerging economies, augmenting screening coverage, improved funding for better R&D in this area, growing awareness regarding STDs in the developing countries along with the increased healthcare expenditures are the factors driving the growth of this market. Also, accessibility to and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Furthermore, improved insurance coverage in the emerging economies augurs well for this market.

However, the stigma associated with sexually transmitted diseases is the primary restraint of market growth.

This market is broadly segmented by product type and end user into diagnostics and therapeutics segments. Classification in diagnostics by product type entails Nucleic Acid Amplification Tests (NAATs), Direct Fluorescent Tests, and PCR. NAAT accounted for the largest market share in 2016 and is predicted to grow robustly in the forecast period. It is closely tailed by DFT in terms of CAGR. This is because NAATs are more sensitive and diagnose better. Classification in diagnostics by end user entails Hospitals, Specialty Clinics, and Diagnostic Centres. Classification in therapeutics by product type entails Macrolides, Quinolones, Sulphonamides, Tetracycline, and Aminopenicillins. Macrolides is expected to undergo high growth in the forecast period. It also captures the largest market share and is expected to stay at the top in the forecast period. Classification in therapeutics by end user entails Hospital Pharmacies, Drugstores, Retail Pharmacies, and Online Pharmacies.

Classification by geography entails UK, Spain, Germany, France and others. It is the second largest market. UK is the market leader. This region is expected to undergo sluggish growth in the forecast period.

Key players in the market include Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product Type                            

                              5.1.1 Introduction           

                              5.1.2 Diagnostics             

                                             5.1.2.1 Nucleic Acid Amplification Tests (NAATs)

                                             5.1.2.2 Direct Fluorescent Tests

                                             5.1.2.3 PCR

                              5.1.3 Therapeutics          

                                             5.1.3.1 Macrolides

                                             5.1.3.2 Quinolones

                                             5.1.3.3 Sulfonamides

                                             5.1.3.4 Tetracycline

                                             5.1.3.5 Aminopenicillins

                              5.1.4 Y-o-Y Growth Analysis, By Product Type     

                              5.1.5 Market Attractiveness Analysis, By Product Type    

                              5.1.6 Market Share Analysis, By Product Type     

               5.2 End User                     

                              5.2.1 Introduction           

                              5.2.2 Diagnostics             

                                             5.2.2.1 Hospitals

                                             5.2.2.2 Specialty Clinics

                                             5.2.2.3 Diagnostic Centers

                              5.2.3 Therapeutics          

                                             5.2.3.1 Hospital Pharmacies

                                             5.2.3.2 Drugstores

                                             5.2.3.3 Retail Pharmacies

                                             5.2.3.4 Online Pharmacies

                              5.2.4 Y-o-Y Growth Analysis, By End User             

                              5.2.5 Market Attractiveness Analysis, By End User            

                              5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product Type

                                             6.1.3.3 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product Type

                                             6.1.4.3 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product Type

                                             6.1.5.3 By End User

               6.2 U.K                

               6.3 Spain                           

               6.4 Germany                     

               6.5 Italy                             

               6.6 France                         

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Bio Rad laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Novartis AG               

               8.3 F Hoffmann-La Roche                           

               8.4 Abbott Laboratories               

               8.5 Danaher                      

               8.6 bioMerieux                

               8.7 DiaSorin SpA                             

               8.8 Siemens AG               

               8.9 Thermo Fisher Scientific                       

               8.10 Becton Dickinson and Company                     

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  2. Europe Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Therapeutics Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)
  5. Europe Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Therapeutics Market, By Region, From 2020 to 2025 (USD Billion)
  7. U.K. Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  8. U.K. Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)
  9. Germany Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  10. Germany Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)
  11. France Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  12. France Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)
  13. Italy Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  14. Italy Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)
  15. Spain Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2020 to 2025 (USD Billion)
  16. Spain Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample